Aytu Biopharma (AYTU) Non Operating Income (2010 - 2023)

Aytu Biopharma (AYTU) has 14 years of Non Operating Income data on file, last reported at -$6.6 million in Q3 2023.

• On a quarterly basis, Non Operating Income fell 697.65% year-over-year to -$6.6 million in Q3 2023; TTM through Sep 2023 was -$7.8 million, a 525.12% decrease from a year earlier, with the FY2023 full-year figure at $14000.0, down 98.62% from the prior year.
• Non Operating Income for Q3 2023 stood at -$6.6 million, down from -$2.6 million in the prior quarter.
• Over the last five years, Non Operating Income for AYTU reached as high as $8.7 million in Q2 2020 and fell as low as -$10.0 million in Q2 2019.
• Historically, Non Operating Income has averaged -$167527.4 across 5 years, with a median of -$195390.0 in 2019.
• Across the five-year window, Non Operating Income surged 4544.74% in 2019 and slumped 697.65% in 2023, its largest moves.
• Year by year, Non Operating Income stood at $4.8 million in 2019, then slumped by 183.11% to -$4.0 million in 2020, then jumped by 93.49% to -$257000.0 in 2021, then soared by 138.91% to $100000.0 in 2022, then sank by 6716.0% to -$6.6 million in 2023.
• Per Business Quant data, the three most recent Non Operating Income figures were -$6.6 million in Q3 2023, -$2.6 million in Q2 2023, and $1.4 million in Q1 2023.